Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder

Journal of ECT

Volumn 24, Issue 1, 2008, Pages 88-91

  Lehtimäki, Kai ^a   Keränen, Tapani ^a   Huuhka, Martti ^a   Palmio, Johanna ^a   Hurme, Mikko ^b   Leinonen, Esa ^a   Peltola, Jukka ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Cytokines; Depressive disorder; Electroconvulsive therapy; Epilepsy; Growth factors; Neuronal plasticity; Seizure

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DEPOLARIZATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MONTGOMERY ASBERG DEPRESSION RATING SCALE;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; STATISTICS, NONPARAMETRIC;

EID: 41849105075     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181571abb     Document Type: Article

References (23)

1. Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998;62:583-606.
2. Maes M, Lin AH, Delmeire L, et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999;45:833-839.
3. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:201-217.
4. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157:1-45.
5. Wahlund B, von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology. 2003;28:21-26.
6. Fischler B, Bocken R, Schneider I, et al. Immune changes induced by electroconvulsive therapy (ECT). Ann N Y Acad Sci. 1992;15:326-330.
7. Kronfol Z, Nair MP, Weinberg V, et al. Acute effects of electroconvulsive therapy on lymphocyte natural killer cell activity in patients with major depression. J Affect Disord. 2002;71:211-215.
8. Hestad KA, Tonseth S, Stoen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19:183-188.
9. Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci. 1999;19:5054-5065.
10. Jankowsky JL, Derrick BE, Patterson PH. Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem. 2000;7:400-412.
11. Lehtimäki KA, Peltola J, Koskikallio E, et al. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res Mol Brain Res. 2003;110:253-260.
12. Lehtimäki KA, Keränen T, Huhtala H, et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol. 2004;152:121-125.
13. Peltola J, Palmio J, Korhonen L, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000;41:205-211.
14. Palmio J, Huuhka M, Saransaari P, et al. Changes in plasma amino acids after electroconvulsive therapy of depressed patients. Psychiatry Res. 2005;137:183-190.
15. Sallmann S, Juttler E, Prinz S, et al. Induction of interleukin-6 by depolarization of neurons. J Neurosci. 2000;20:8637-8642.
16. Swartz CM. Electroconvulsive therapy stimulus dose expressed as volume of seizure foci. J ECT. 2006;22:54-58.
17. Sluzewska A, Rybakowski J, Bosmans E, et al. Indicators of immune activation in major depression. Psychiatry Res. 1996;64:161-167.
18. Maes M, Bosmans E, De Jongh R, et al. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-858.
19. Penninx BW, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003;54:566-572.
20. Owen BM, Eccleston D, Ferrier IN, et al. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand. 2001;103:226-228.
21. Kossmann T, Hans V, Imhof HG, et al. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 1996;713:143-152.
22. März P, Heese K, Dimitriades-Schmutz B, et al. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia. 1999;26:191-200.
23. Juric DM, Carman-Krzan M. Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor. Int J Dev Neurosci. 2001;19:675-683.